In December [2023], the World Health Organization (WHO) issued a pre-qualification approval for the novel oral polio vaccine type 2 (nOPV2), which will expand access.
The news brief appeared in the April 2024 PRM Issue. Read more: https://www.philippinerotarymagazine.com/magazines/202404prm SHARE THE NEWS Facebook I LinkedIn I Instagram I YouTube LEARN MORE 👉 Vaccine innovation: novel oral polio vaccine type 2 (nOPV2)
👉 Safety profile of nOPV2 vaccine https://www.who.int/groups/global-advisory-committee-on-vaccine-safety/topics/poliovirus-vaccines 👉 GPEI Webinar: Introduction to nOPV2 https://www.youtube.com/watch?v=7oMKC0WeiC8
Comentários